Sanofi warns on '13 profit as Q2 earns slump (Update)
Competition from generic drugs continued to hammer French pharmaceutical group Sanofi in the second quarter, the company said Thursday, warning that its full-year earnings could be twice as bad as previous guidance.
Aug 1, 2013
0
0